Cargando…
Circulating tumor cells capture disease evolution in advanced prostate cancer
BACKGROUND: Genetic analysis of advanced cancer is limited by availability of representative tissue. Biopsies of prostate cancer metastasized to bone are invasive with low quantity of tumor tissue. The prostate cancer genome is dynamic, however, with temporal heterogeneity requiring repeated evaluat...
Autores principales: | Lack, Justin, Gillard, Marc, Cam, Maggie, Paner, Gladell P., VanderWeele, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322599/ https://www.ncbi.nlm.nih.gov/pubmed/28228136 http://dx.doi.org/10.1186/s12967-017-1138-3 |
Ejemplares similares
-
Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer – A Case Report
por: VanderWeele, David J., et al.
Publicado: (2015) -
Prostate cancer: a presentation of clinicopathologic prognosticators among Filipino and American men at radical prostatectomy
por: Grageda, Mayen T, et al.
Publicado: (2021) -
Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer
por: Saoud, Ragheed, et al.
Publicado: (2020) -
Antibody-drug conjugates and predictive biomarkers in advanced urothelial carcinoma
por: Fenton, Sarah E., et al.
Publicado: (2023) -
Low-grade prostate cancer diverges early from high grade and metastatic disease
por: VanderWeele, David J, et al.
Publicado: (2014)